Cargando…
Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats
BACKGROUND: Activation of heme oxygenase-1 (HO-1) has been proved to reduce damages to the liver in ischemia reperfusion injury. The objective of present study was to determine whether clinic relevant doses of isoflurane treatment could be sufficient to activate HO-1 inducing, which confers protecti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088533/ https://www.ncbi.nlm.nih.gov/pubmed/21453462 http://dx.doi.org/10.1186/1471-230X-11-31 |
_version_ | 1782202906494107648 |
---|---|
author | Lv, Xin Yang, Liqun Tao, Kunming Liu, Yantao Yang, Tian Chen, Guozhong Yu, Weifeng Lv, Hao Wu, Feixiang |
author_facet | Lv, Xin Yang, Liqun Tao, Kunming Liu, Yantao Yang, Tian Chen, Guozhong Yu, Weifeng Lv, Hao Wu, Feixiang |
author_sort | Lv, Xin |
collection | PubMed |
description | BACKGROUND: Activation of heme oxygenase-1 (HO-1) has been proved to reduce damages to the liver in ischemia reperfusion injury. The objective of present study was to determine whether clinic relevant doses of isoflurane treatment could be sufficient to activate HO-1 inducing, which confers protective effect against hepatic ischemia-reperfusion injury. METHODS: The hepatic artery and portal vein to the left and the median liver lobes of forty male Sprague-Dawley rats were occluded for 60 minutes. Reperfusion was allowed for 4 hours before the animal subjects were sacrificed. Six groups (n = 12) were included in the study. A negative control group received sham operation and positive control group a standard ischemia-reperfusion regimen. The third group was pretreated with isoflurane prior to the ischemia-reperfusion. The fourth group received an HO-1 inhibitor zinc protoporphyrin (Znpp) prior to the isoflurane pretreatment and the ischemia-reperfusion. The fifth group received Znpp alone before ischemia-reperfusion procedure, and the sixth group was administrated with a HO-1 inducer hemin prior to IR. HO-1 in the liver was measured using an enzymatic activity assay, a Western blot analysis, as well as immunohistochemical method. Extent of liver damage was estimated by determination of the serum transaminases, liver lipid peroxidation and hepatic histology. Infiltration of the liver by neutrophils was measured using a myeloperoxidase activity assay. TNFα mRNA in the liver was measured using RT-PCR. RESULTS: Isoflurane pretreatment significantly attenuated the hepatic injuries and inflammatory responses caused by the ischemia reperfusion. Selectively inhibiting HO-1 with ZnPP completed blocked the protective effects of isoflurane. Inducing HO-1 with hemin alone produced protective effects similar in magnitude to that of isoflurane. CONCLUSIONS: Clinic relevant doses of isoflurane attenuate ischemia reperfusion injury in rats by increasing the HO-1 expression and activity. |
format | Text |
id | pubmed-3088533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30885332011-05-06 Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats Lv, Xin Yang, Liqun Tao, Kunming Liu, Yantao Yang, Tian Chen, Guozhong Yu, Weifeng Lv, Hao Wu, Feixiang BMC Gastroenterol Research Article BACKGROUND: Activation of heme oxygenase-1 (HO-1) has been proved to reduce damages to the liver in ischemia reperfusion injury. The objective of present study was to determine whether clinic relevant doses of isoflurane treatment could be sufficient to activate HO-1 inducing, which confers protective effect against hepatic ischemia-reperfusion injury. METHODS: The hepatic artery and portal vein to the left and the median liver lobes of forty male Sprague-Dawley rats were occluded for 60 minutes. Reperfusion was allowed for 4 hours before the animal subjects were sacrificed. Six groups (n = 12) were included in the study. A negative control group received sham operation and positive control group a standard ischemia-reperfusion regimen. The third group was pretreated with isoflurane prior to the ischemia-reperfusion. The fourth group received an HO-1 inhibitor zinc protoporphyrin (Znpp) prior to the isoflurane pretreatment and the ischemia-reperfusion. The fifth group received Znpp alone before ischemia-reperfusion procedure, and the sixth group was administrated with a HO-1 inducer hemin prior to IR. HO-1 in the liver was measured using an enzymatic activity assay, a Western blot analysis, as well as immunohistochemical method. Extent of liver damage was estimated by determination of the serum transaminases, liver lipid peroxidation and hepatic histology. Infiltration of the liver by neutrophils was measured using a myeloperoxidase activity assay. TNFα mRNA in the liver was measured using RT-PCR. RESULTS: Isoflurane pretreatment significantly attenuated the hepatic injuries and inflammatory responses caused by the ischemia reperfusion. Selectively inhibiting HO-1 with ZnPP completed blocked the protective effects of isoflurane. Inducing HO-1 with hemin alone produced protective effects similar in magnitude to that of isoflurane. CONCLUSIONS: Clinic relevant doses of isoflurane attenuate ischemia reperfusion injury in rats by increasing the HO-1 expression and activity. BioMed Central 2011-03-31 /pmc/articles/PMC3088533/ /pubmed/21453462 http://dx.doi.org/10.1186/1471-230X-11-31 Text en Copyright ©2011 Lv et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lv, Xin Yang, Liqun Tao, Kunming Liu, Yantao Yang, Tian Chen, Guozhong Yu, Weifeng Lv, Hao Wu, Feixiang Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title | Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title_full | Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title_fullStr | Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title_full_unstemmed | Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title_short | Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats |
title_sort | isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088533/ https://www.ncbi.nlm.nih.gov/pubmed/21453462 http://dx.doi.org/10.1186/1471-230X-11-31 |
work_keys_str_mv | AT lvxin isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT yangliqun isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT taokunming isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT liuyantao isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT yangtian isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT chenguozhong isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT yuweifeng isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT lvhao isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats AT wufeixiang isofluranepreconditioningatclinicallyrelevantdosesinduceprotectiveeffectsofhemeoxygenase1onhepaticischemiareperfusioninrats |